All News about Novartis Ag ADR
Novartis AG (NYSE: NVS) Records 52-Week High Friday Morning
January 05, 2024
![]() ![]()
Big Players' Recent Trades in NVS Options
January 04, 2024
Via Benzinga
![]() ![]() ![]() ![]()
(NVS) - Analyzing Novartis's Short Interest
December 20, 2023
Via Benzinga
![]()
(NVS) - Analyzing Novartis's Short Interest
December 01, 2023
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]()
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]()
FDA Approves Merck's Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patients
December 15, 2023
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]()
Novartis' Rare Blood Disorder Therapy Scores FDA Approval
December 06, 2023
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|